Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 2
1971 2
1975 1
1985 1
1998 1
2001 5
2003 3
2004 1
2006 2
2007 1
2009 2
2010 1
2011 5
2012 3
2013 3
2014 3
2015 5
2016 6
2017 8
2018 13
2019 6
2020 4
2021 8
2022 4
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

84 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for guillaume e[au]
Your search for Wuillaume E[au] retrieved no results
Radiothérapie et immunothérapie.
Rancoule C, Vallard A, Jmour O, Vial N, Guillaume E, Guy JB, Magné N. Rancoule C, et al. Among authors: guillaume e. Bull Cancer. 2018 Dec;105 Suppl 1:S92-S100. doi: 10.1016/S0007-4551(18)30394-1. Bull Cancer. 2018. PMID: 30595203 Review. French.
A Phase 3 Trial of l-Glutamine in Sickle Cell Disease.
Niihara Y, Miller ST, Kanter J, Lanzkron S, Smith WR, Hsu LL, Gordeuk VR, Viswanathan K, Sarnaik S, Osunkwo I, Guillaume E, Sadanandan S, Sieger L, Lasky JL, Panosyan EH, Blake OA, New TN, Bellevue R, Tran LT, Razon RL, Stark CW, Neumayr LD, Vichinsky EP; Investigators of the Phase 3 Trial of l-Glutamine in Sickle Cell Disease. Niihara Y, et al. Among authors: guillaume e. N Engl J Med. 2018 Jul 19;379(3):226-235. doi: 10.1056/NEJMoa1715971. N Engl J Med. 2018. PMID: 30021096 Free article. Clinical Trial.
Microbiote intestinal : qu’en attendre au plan physiologique et thérapeutique ?
Doré J, Multon MC, Béhier JM; les participants à la table ronde 2 des Ateliers de Giens XXXII; Affagard H, Andremont A, Barthélémy P, Batista R, Bonneville M, Bonny C, Boyaval G, Chamaillard M, Chevalier MP, Cordaillat-Simmons M, Cournarie F, Diaz I, Guillaume E, Guyard C, Jouvin-Marche E, Martin FP, Petiteau D. Doré J, et al. Among authors: guillaume e. Therapie. 2017 Feb;72(1):1-19. doi: 10.1016/j.therap.2017.01.001. Epub 2017 Jan 11. Therapie. 2017. PMID: 28214070 French. No abstract available.
[Radiotherapy and immune suppression: A short review].
Bosacki C, Vallard A, Jmour O, Ben Mrad M, Lahmamssi C, Bousarsar A, Vial N, Guillaume E, Daguenet E, Magné N. Bosacki C, et al. Among authors: guillaume e. Bull Cancer. 2020 Jan;107(1):84-101. doi: 10.1016/j.bulcan.2019.09.010. Epub 2019 Dec 19. Bull Cancer. 2020. PMID: 31866074 Review. French.
Navigating the highlights of phase III trials: a watchful eye on evidence-based radiotherapy.
Trone JC, Espenel S, Rehailia-Blanchard A, Guillaume E, Vial N, Rancoule C, Rodriguez-Lafrasse C, Ben Mrad M, El Meddeb Hamrouni A, Ollier E, Chargari C, Deutsch E, Vallard A, Magné N. Trone JC, et al. Among authors: guillaume e. Ann Oncol. 2017 Nov 1;28(11):2691-2697. doi: 10.1093/annonc/mdx347. Ann Oncol. 2017. PMID: 29045516 Free article. Review.
84 results